ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,776,000 | +313.0% | 142,761 | +354.4% | 0.00% | +100.0% |
| Q3 2016 | $430,000 | +87.0% | 31,417 | +1.1% | 0.00% | – |
| Q2 2016 | $230,000 | +21.7% | 31,087 | +5.0% | 0.00% | – |
| Q1 2016 | $189,000 | +4.4% | 29,619 | +2.1% | 0.00% | – |
| Q4 2015 | $181,000 | +9.7% | 29,015 | +2.4% | 0.00% | – |
| Q3 2015 | $165,000 | -31.0% | 28,326 | -1.9% | 0.00% | – |
| Q2 2015 | $239,000 | +9.1% | 28,864 | +8.6% | 0.00% | – |
| Q1 2015 | $219,000 | +19.7% | 26,583 | -0.1% | 0.00% | – |
| Q4 2014 | $183,000 | -1.1% | 26,613 | -22.3% | 0.00% | – |
| Q3 2014 | $185,000 | -15.1% | 34,263 | 0.0% | 0.00% | – |
| Q2 2014 | $218,000 | -95.1% | 34,263 | -85.8% | 0.00% | -100.0% |
| Q3 2013 | $4,439,000 | +5.2% | 241,230 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $4,219,000 | – | 241,230 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |